Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ledifos Ledipasvir 90mg And Sofosbuvir 400mg Tablets:
Ledifos combines Ledipasvir and Sofosbuvir in a single tablet, providing an effective treatment option for patients with chronic hepatitis C virus (HCV) infection. This innovative formulation supports optimal viral suppression and enhances treatment adherence.
Uses of Ledifos Ledipasvir 90mg And Sofosbuvir 400mg Tablets:
Ledifos is indicated for:
Treatment of chronic hepatitis C virus (HCV) infection in adults
Applicable for all genotypes of HCV, providing broad-spectrum efficacy
Benefits of Ledifos Ledipasvir 90mg And Sofosbuvir 400mg Tablets:
Highly effective in achieving sustained virologic response (SVR)
Well-tolerated with a favorable safety profile
Convenient once-daily dosing for improved patient compliance
Supports the elimination of HCV and restoration of liver health
Mechanism of Action of Ledifos Ledipasvir 90mg And Sofosbuvir 400mg Tablets:
Ledipasvir and Sofosbuvir work in tandem to combat HCV. Ledipasvir inhibits the NS5A protein, essential for viral replication, while Sofosbuvir inhibits the NS5B polymerase, preventing RNA synthesis. This dual-action mechanism effectively disrupts the life cycle of the virus, leading to a higher chance of cure.